An Alternative SplicedRNASELVariant in Peripheral Blood Leukocytes
- 1 November 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 26 (11) , 820-826
- https://doi.org/10.1089/jir.2006.26.820
Abstract
2-5A-Dependent RNase L is an endoribonuclease that catalyzes RNA degradation and promotes apoptosis during the innate antiviral response in mammalian cells. Prior studies showed that RNASEL is widely expressed and suggested the presence of mRNA species of different sizes but lacked a characterization of these variants. Using RT-PCR, we show that RNASEL is expressed in all human tissues examined, whereas an alternatively generated spliced variant lacking the third exon (RNASEL del_Ex3) is solely expressed in peripheral blood leukocytes (PBL). Quantitative RT-PCR measurements of RNA from different PBL cell types separated by fluorescence activated cell sorting (FACS) showed that complete RNASEL mRNA levels were significantly elevated in granulocytes compared with all other PBL cell types, whereas expression was lowest in CD8+ T cells. The alternatively spliced RNASEL del_Ex3 transcript was present in all PBL cell types examined but at lower levels than the full-length RNASEL mRNA. The presence of high levels of RNase L protein in granulocytes was confirmed by immunohistochemistry. Our findings are the first to demonstrate the presence of an alternatively spliced RNASEL mRNA and to demonstrate the variable expression of RNase L in different leukocytes. Our results suggest that RNase L plays an important role in granulocytes as an innate immunity enzyme that controls viral infections.Keywords
This publication has 32 references indexed in Scilit:
- Mapping of the Human RNASEL Promoter and Expression in Cancer and Normal CellsJournal of Interferon & Cytokine Research, 2005
- HPC1/RNASEL Mediates Apoptosis of Prostate Cancer Cells Treated with 2′,5′-Oligoadenylates, Topoisomerase I Inhibitors, and Tumor Necrosis Factor-Related Apoptosis-Inducing LigandCancer Research, 2004
- Reduced Infiltration of Class A Scavenger Receptor Positive Antigen-Presenting Cells Is Associated with Prostate Cancer ProgressionCancer Research, 2004
- Implications for RNase L in Prostate Cancer BiologyBiochemistry, 2003
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- A Novel Founder Mutation in the RNASEL Gene, 471delAAAG, Is Associated with Prostate Cancer in Ashkenazi JewsAmerican Journal of Human Genetics, 2002
- Germline Alterations of the RNASEL Gene, a Candidate HPC1 Gene at 1q25, in Patients and Families with Prostate CancerAmerican Journal of Human Genetics, 2002
- Localization of a Molecular Form of Interferon-Regulated RNase L in the CytoskeletonJournal of Interferon & Cytokine Research, 1998
- Characterization of two murine (2′‐5′)(A)n‐dependent endonucleases of different molecular massEuropean Journal of Biochemistry, 1989
- Distribution of the ppp(A2′p)nA-binding protein and interferon-related enzymes in animals, plants, and lower organismsBiochemical and Biophysical Research Communications, 1982